Blair Williams Todt - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP and Chief Legal Officer
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2023
Net transactions value: -$174,479
Form type: 4
Filing time: 03 Mar 2023, 15:25:44 UTC
Previous filing: 05 Jan 2023
Next filing: 05 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$174,479	-372	-4.5%	$469.03	7,911	01 Mar 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,133	+27%	$0.000000	10,044	01 Mar 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+2,584	+26%	$0.000000	12,628	01 Mar 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8,195		$0.000000	8,195	01 Mar 2023	Common Stock	8,195	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 12/1/2023.
F4	The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.